Altium Capital Management »

Biovie shares owned by Altium Capital Management

Quarter-by-quarter ownership of Biovie (BIVI) shares owned by Altium Capital Management from 13F filings

Historical chart of Altium Capital Management investment in Biovie

Tip: Access up to 7 years of quarterly data

All positions including Biovie held by Altium Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biovie by Altium Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.6M 3.0M 0.53

More positions owned by Altium Capital Management

Vera Therapeutics Cl A (VERA)
Xenon Pharmaceuticals (XENE)
Viking Therapeutics Put Put Option
Advisorshares Tr Call Call Option
Axsome Therapeutics (AXSM)
Adma Biologics (ADMA)
Alimera Sciences Com New (ALIM)
Avadel Pharmaceuticals Sponsored Adr (AVDL)
Xtant Med Hldgs Com New (XTNT)
Catalyst Pharmaceutical Partners (CPRX)
Intra Cellular Therapies (ITCI)
Biohaven (BHVN)
Viking Therapeutics (VKTX)
Olema Pharmaceuticals (OLMA)
Savara (SVRA)

View all positions for Altium Capital Management

Top funds holding Biovie

Altium Capital Management
Sabby Management
Vanguard Group
CVI Holdings
Renaissance Technologies
BlackRock
Susquehanna International
Geode Capital Management
State Street Corporation
Northern Trust
Citadel Advisors
HPM Partners
Sheaff Brock Investment Advisors
Envestnet Asset Management
Bank of America Corporation

View all funds holding Biovie